Clinical MicroArrays Inc.
This article was originally published in Start Up
Executive Summary
Clinical MicroArrays Inc. is developing a multi-analyte protein-chip based system that is easier and cheaper to run than even the standard ELISA immunoassays.
You may also be interested in...
Clinical Research Tools: A Special Situation for Venture Investors and Entrepreneurs
Five years after the genomics bubble burst and financing doors shut, a small window may be opening for research tool suppliers that help pharma improve R&D efficiency and cost structure. But clinically-oriented research companies face particular challenges, notably how to build a business where customer adoption is slow but technology is evolving rapidly and investors are impatient.
Clinical Research Tools: A Special Situation for Venture Investors and Entrepreneurs
Five years after the genomics bubble burst and financing doors shut, a small window may be opening for research tool suppliers that help pharma improve R&D efficiency and cost structure. But clinically-oriented research companies face particular challenges, notably how to build a business where customer adoption is slow but technology is evolving rapidly and investors are impatient.
Biosite: Building a Solid Franchise
Biosite is one of a few diagnostic companies that has had to grapple with a literal run on its product--a point-of-care proprietary cardiovascular test that took off in the marketplace almost immediately after it was introduced in 2000. Now, it faces two challenges: the advent of competition from large in-vitro diagnostic companies and following up with a seond act as its explosive growth slows to more normal levels.